Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's Why

Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?

AbbVie (NYSE:ABBV) Trading Down 2.5% - Here's What Happened - Stock Observer

11 Debt Free Halal Stocks to Buy

If You Have $500,000 Saved at 60, Here's The Sort of Monthly Income You Can Count On

Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Nottingham biotech lands licensing deal with pharma giant AbbVie | TheBusinessDesk.com

Martingale Asset Management L P Sells 14,724 Shares of AbbVie Inc. $ABBV - Markets Daily

Invesco Ltd. Raises Stock Holdings in AbbVie Inc. $ABBV

Sei Investments Co. Increases Holdings in AbbVie Inc. $ABBV

Advisory Research Inc. Buys 9,880 Shares of AbbVie Inc. $ABBV

AbbVie Inc. (NYSE:ABBV) Receives Average Rating of "Moderate Buy" from Brokerages

AbbVie CEO Robert Michael got big pay hike in 2025

The Best Dividend Stocks to Buy and Hold Forever

Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer

AbbVie (NYSE:ABBV) Shares Down 1% - What's Next? - Daily Political

Avalo Therapeutics CEO Teases Q2 Top-Line Data for AVTX-009 Phase 2b HS LOTUS Trial at Conference - Markets Daily

AbbVie Inc. $ABBV Shares Sold by Van ECK Associates Corp

Douglass Winthrop Advisors LLC Grows Stock Position in AbbVie Inc. $ABBV - Markets Daily

Bokf Na Sells 8,422 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Holdings Cut by Bokf Na | MarketBeat

RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages

AbbVie Reports Promising Results from Phase 1 Study of ABBV-295

AbbVie Inc. $ABBV Holdings Cut by Bokf Na - Stock Observer

How The Narrative For AbbVie (ABBV) Is Shifting On Immunology Growth And Competition Risks

Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight

Josh Brown: Biotech growth stocks immune to disruption risk

AbbVie's ABBV-295 Obesity Data Sparks Fresh Interest In Valuation

Market Downturn: 2 Stocks to Buy and Hold Through Any Storm

SageView Advisory Group LLC Buys 13,883 Shares of AbbVie Inc. $ABBV - Markets Daily

Mackenzie Financial Corp Sells 99,604 Shares of AbbVie Inc. $ABBV

Franklin Resources Inc. Trims Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Franklin Resources Inc. - Stock Observer

Kepler Cheuvreux Suisse SA Takes $7.54 Million Position in AbbVie Inc. $ABBV - Daily Political

Immunophenotypic changes following menin inhibition in acute myeloid leukemia

abbvie hosts national media conclave on world glaucoma week

AbbVie's GLP-1 challenger shows early weight loss promise - Crain's Chicago Business

Capital International Investors Has $2.48 Billion Stock Holdings in AbbVie Inc. $ABBV - Markets Daily

Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - Markets Daily

Claret Asset Management Corp Has $27.53 Million Position in AbbVie Inc. $ABBV - Markets Daily

Is It Too Late To Consider AbbVie (ABBV) After A Strong Multi Year Run?

Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - Stock Observer

Elahere (AbbVie: mirvetuximab soravtansine-gynx) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Bank of Montreal Can Raises Stock Position in AbbVie Inc. $ABBV

ABBV: Future Returns Will Depend On Immunology Encore And Deal Optionality Uncertainty

Richard Bernstein Advisors LLC Cuts Stock Holdings in AbbVie Inc. $ABBV - Daily Political

B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?

Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study

AbbVie (NYSE:ABBV) Shares Down 1% Following Insider Selling

Biotech is resistant to AI disruption. Josh Brown likes these two stocks in the industry

REGENXBIO To Report Duchenne Muscular Dystrophy Trial Results In Early Q2 2026

AbbVie Trial Updates Add Context To Valuation And Growth Outlook

Sienna Gestion Boosts Stock Holdings in AbbVie Inc. $ABBV

AbbVie Reports Positive Topline Results In Phase 1 Study For ABBV-295 In Weight Management

AbbVie Inc. $ABBV Shares Purchased by Schroder Investment Management Group

Swiss National Bank Trims Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by LGT Group Foundation

Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks

AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn's Disease

First Trust Advisors LP Sells 1,007,670 Shares of AbbVie Inc. $ABBV

Private Advisor Group LLC Sells 3,553 Shares of AbbVie Inc. $ABBV - Daily Political

LGT Group Foundation Increases Position in AbbVie Inc. $ABBV - Daily Political

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer

This 5-Star ETF Pays Monthly Dividends and Has Never Missed in 19 Years

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript

Natixis Advisors LLC Sells 4,569 Shares of AbbVie Inc. $ABBV

Korea Investment CORP Acquires 188,587 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Rhenman & Partners Asset Management AB

Vinva Investment Management Ltd Purchases 31,451 Shares of AbbVie Inc. $ABBV - Stock Observer

Gabelli Funds LLC Decreases Stake in AbbVie Inc. $ABBV

Korea Investment CORP Purchases 188,587 Shares of AbbVie Inc. $ABBV - Stock Observer

Pharmaceutical Stocks To Research - March 7th - Stock Observer

Munich Reinsurance Co Stock Corp in Munich Invests $47.60 Million in AbbVie Inc. $ABBV - Markets Daily

Guardian Capital LP Grows Position in AbbVie Inc. $ABBV

Is AbbVie (ABBV) Still Priced Attractively After Its Strong Multi Year Share Price Run

Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study

AbbVie (NYSE:ABBV) SVP David Ryan Purdue Sells 5,230 Shares

Top Medical Stocks To Follow Today - March 6th - Markets Daily

Invest Like Warren Buffett with These ETFs

Integrity Advisory Solutions LLC Takes $747,000 Position in AbbVie Inc. $ABBV - Markets Daily

Edgar Lomax Co. VA Reduces Stock Position in AbbVie Inc. $ABBV

Weekly Investment Analysts' Ratings Changes for AbbVie (ABBV) - Daily Political

Crossmark Global Holdings Inc. Raises Holdings in AbbVie Inc. $ABBV

Berry Wealth Group LP Lowers Stake in AbbVie Inc. $ABBV

Avalo Therapeutics Highlights AVTX-009 Plan, Near-Term Phase II HS Data at Healthcare Conference - Daily Political

AbbVie Expands US AI Manufacturing As Risankizumab Trial Supports Valuation Gap

Did Positive Phase 3 SKYRIZI Crohn's Data Just Shift AbbVie's (ABBV) Immunology Investment Narrative?

Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia

AbbVie (NYSE:ABBV) Trading Down 1.7% - What's Next?

REGENXBIO (NASDAQ:RGNX) Releases Earnings Results, Misses Estimates By $0.31 EPS - Stock Observer

Medical Stocks To Add to Your Watchlist - March 5th - Stock Observer

REGENXBIO Reports Fourth Quarter and Full Year 2025 Financia

Cambria Investment Management L.P. Makes New $729,000 Investment in AbbVie Inc. $ABBV - Stock Observer